Publications by authors named "Kelly T Smith"

Claim this Profile
D
Distal cholangiocarcinoma: case report and brief review of the literature.
Quincy A Hathaway, Dhairya A Lakhani, Aneri B Balar, Stell P Santiago, Matthew R Krafft, Kelly T Smith

Radiol Case Rep· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64).
Rick Daniel Vavolizza, Gina R Petroni, Ileana S Mauldin, Kimberly A Chianese-Bullock, Walter C Olson, Kelly T Smith

J Immunother Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Giant mediastinal bronchial artery aneurysm mimicking mediastinal mass: A case report and brief review of the literature.
Aneri B Balar, Dhairya A Lakhani, Daniel Martin, Kelly T Smith, Cathy Kim

Radiol Case Rep· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Congenital adrenal hyperplasia with associated giant adrenal myelolipoma, testicular adrenal rest tumors and primary pigmented nodular adrenocortical disease: A case report and brief review of the literature.
Aaron Jacobson, Elaine Koberlein, Alan Thomay, Cara B Lombard, Ayodele Adelanwa, Kelly T Smith

Radiol Case Rep· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulomatosis with polyangiitis: A case report and brief review of literature.
Dhairya A Lakhani, Aneri B Balar, Ayodele Adelanwa, Alexander Gross, Rehab Mohamed, Kelly T Smith

Radiol Case Rep· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund's adjuvant (IFA) for resected high-risk melanoma.
Sapna P Patel, Gina R Petroni, Jason Roszik, Walter C Olson, Nolan A Wages, Kelly T Smith

J Immunother Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of NY-ESO-1 vaccine + anti-CTLA4 antibody Ipilimumab (IPI) in patients with unresectable or metastatic melanoma.
Craig L Slingluff, Hassane M Zarour, Hussein Abdul-Hassan Tawbi, John M Kirkwood, Michael A Postow, Kelly T Smith

Oncoimmunology· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund's adjuvant, cyclophosphamide, and polyICLC (Mel63).
Craig L Slingluff, Gina R Petroni, Kimberly A Chianese-Bullock, Nolan A Wages, Walter C Olson, Kelly T Smith

J Immunother Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma.
Victor H Engelhard, Rebecca C Obeng, Kara L Cummings, Gina R Petroni, Angela L Ambakhutwala, Kelly T Smith

J Immunother Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patients.
Marit M Melssen, Gina R Petroni, Kimberly A Chianese-Bullock, Nolan A Wages, William W Grosh, Kelly T Smith

J Immunother Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer.
Patrick M Dillon, Gina R Petroni, Mark E Smolkin, David R Brenin, Kimberly A Chianese-Bullock, Kelly T Smith

J Immunother Cancer· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases.
Ileana S Mauldin, Nolan A Wages, Anne M Stowman, Ena Wang, Mark E Smolkin, Kelly T Smith

Cancer Immunol Immunother· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases.
Ileana S Mauldin, Nolan A Wages, Anne M Stowman, Ena Wang, Walter C Olson, Kelly T Smith

Cancer Immunol Immunother· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sites.
Craig L Slingluff, Gina R Petroni, Walter C Olson, Mark E Smolkin, Kimberly A Chianese-Bullock, Kelly T Smith

Cancer Immunol Immunother· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of spontaneous systemic immunity to melanoma associated with cure after amputation for extensive regional recurrence.
Joshua M Judge, Louis B Brill, Kelly T Smith, Donna H Deacon, James W Patterson

Cancer Immunol Immunother· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis